HEADER IMMUNE SYSTEM 29-JUN-23 8TBP TITLE HLA-DRB1*15:01 IN COMPLEX WITH SMITH ANTIGEN COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: MHC CLASS II ANTIGEN DRA; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DRB1 BETA CHAIN; COMPND 8 CHAIN: B, D; COMPND 9 SYNONYM: HUMAN LEUKOCYTE ANTIGEN DRB1,HLA-DRB1; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: SMALL NUCLEAR RIBONUCLEOPROTEIN-ASSOCIATED PROTEIN N COMPND 13 PEPTIDE; COMPND 14 CHAIN: E, F; COMPND 15 SYNONYM: SMITH ANTIGEN,SNRNP-N,SM PROTEIN D,SM-D,SM PROTEIN N,SM-N, COMPND 16 SMN,TISSUE-SPECIFIC-SPLICING PROTEIN; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-DRA, HLA-DRA1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: HLA-DRB1; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 GENE: SNRPN, HCERN3, SMN; SOURCE 24 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 25 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 26 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 27 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F KEYWDS HUMAN LEUKOCYTE ANTIGEN, HLA, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, KEYWDS 2 IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR Y.T.TING,A.BROURY,J.OOI REVDAT 1 21-FEB-24 8TBP 0 JRNL AUTH P.J.EGGENHUIZEN,R.M.Y.CHEONG,C.LO,J.CHANG,B.H.NG,Y.T.TING, JRNL AUTH 2 J.A.MONK,K.L.LOH,A.BROURY,E.S.V.TAY,C.SHEN,Y.ZHONG,S.LIM, JRNL AUTH 3 J.X.CHUNG,R.KANDANE-RATHNAYAKE,R.KOELMEYER,A.HOI,A.CHAUDHRY, JRNL AUTH 4 P.MANZANILLO,S.L.SNELGROVE,E.F.MORAND,J.D.OOI JRNL TITL SMITH-SPECIFIC REGULATORY T CELLS HALT THE PROGRESSION OF JRNL TITL 2 LUPUS NEPHRITIS. JRNL REF NAT COMMUN V. 15 899 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38321013 JRNL DOI 10.1038/S41467-024-45056-X REMARK 2 REMARK 2 RESOLUTION. 3.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.326 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 24741 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.939 REMARK 3 FREE R VALUE TEST SET COUNT : 1222 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 6.4977 - 5.1595 1.00 2663 137 0.1998 0.3006 REMARK 3 2 5.1595 - 4.5079 1.00 2617 142 0.1640 0.2049 REMARK 3 3 4.5079 - 4.0960 1.00 2620 130 0.1693 0.2132 REMARK 3 4 4.0960 - 3.8025 1.00 2570 132 0.2015 0.2728 REMARK 3 5 3.8025 - 3.5784 1.00 2611 132 0.2085 0.2784 REMARK 3 6 3.5784 - 3.3993 1.00 2540 134 0.2291 0.2672 REMARK 3 7 3.3993 - 3.2513 1.00 2594 121 0.2467 0.3197 REMARK 3 8 3.2513 - 3.1262 0.98 2478 142 0.3003 0.3526 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.407 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.204 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 6434 REMARK 3 ANGLE : 0.732 8769 REMARK 3 CHIRALITY : 0.046 948 REMARK 3 PLANARITY : 0.005 1147 REMARK 3 DIHEDRAL : 17.279 3791 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TBP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1000275611. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95373 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24942 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.120 REMARK 200 RESOLUTION RANGE LOW (A) : 46.931 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 16.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.33 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M DISODIUM MALON 20% W/V PEG 3350, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 147.10000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.54000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.54000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 220.65000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.54000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.54000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 73.55000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.54000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.54000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 220.65000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.54000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.54000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 73.55000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 147.10000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 1 REMARK 465 LYS A 2 REMARK 465 GLU A 3 REMARK 465 THR A 182 REMARK 465 GLY B 1 REMARK 465 ILE C 1 REMARK 465 LYS C 2 REMARK 465 GLU C 3 REMARK 465 THR C 182 REMARK 465 GLY D 1 REMARK 465 ARG E 301 REMARK 465 ARG F 301 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 38 CG CD CE NZ REMARK 470 LYS A 39 CG CD CE NZ REMARK 470 LYS B 105 CG CD CE NZ REMARK 470 ARG C 100 CG CD NE CZ NH1 NH2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU B 35 CD REMARK 480 GLU D 35 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 46 NH2 ARG B 48 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 100 15.73 57.73 REMARK 500 ASP A 142 35.62 -89.07 REMARK 500 LEU A 144 -157.60 -101.15 REMARK 500 THR B 21 10.02 -142.96 REMARK 500 ASN B 33 -102.27 35.60 REMARK 500 ASN B 62 -18.20 80.67 REMARK 500 ASP B 76 -61.72 -92.70 REMARK 500 THR B 90 -70.19 -126.91 REMARK 500 LYS B 105 10.90 53.24 REMARK 500 PRO B 108 154.80 -45.14 REMARK 500 GLN B 110 58.21 -148.20 REMARK 500 HIS B 111 -162.05 -118.73 REMARK 500 PRO B 124 -152.19 -69.63 REMARK 500 TRP B 153 36.22 76.16 REMARK 500 PRO B 178 -19.56 -48.88 REMARK 500 LYS C 111 41.44 72.23 REMARK 500 THR C 135 -149.70 -86.43 REMARK 500 ASP C 142 40.68 -72.45 REMARK 500 HIS C 143 28.49 37.45 REMARK 500 LEU C 144 -152.91 -92.94 REMARK 500 ASP C 171 -70.67 -75.88 REMARK 500 ASN D 33 -106.41 45.95 REMARK 500 VAL D 44 -6.07 -147.95 REMARK 500 GLU D 52 -6.14 -49.20 REMARK 500 ALA D 73 48.15 -87.50 REMARK 500 TYR D 78 -58.29 -124.67 REMARK 500 LYS D 139 61.18 -110.41 REMARK 500 TRP D 153 31.62 71.00 REMARK 500 REMARK 500 REMARK: NULL DBREF 8TBP A 1 182 UNP P01903 DRA_HUMAN 26 207 DBREF 8TBP B 1 190 UNP P01911 DRB1_HUMAN 30 219 DBREF 8TBP C 1 182 UNP P01903 DRA_HUMAN 26 207 DBREF 8TBP D 1 190 UNP P01911 DRB1_HUMAN 30 219 DBREF 8TBP E 301 315 UNP P63162 RSMN_HUMAN 65 79 DBREF 8TBP F 301 315 UNP P63162 RSMN_HUMAN 65 79 SEQADV 8TBP THR A 182 UNP P01903 ALA 207 CONFLICT SEQADV 8TBP GLY B 86 UNP P01911 VAL 115 VARIANT SEQADV 8TBP THR C 182 UNP P01903 ALA 207 CONFLICT SEQADV 8TBP GLY D 86 UNP P01911 VAL 115 VARIANT SEQRES 1 A 182 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 A 182 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 A 182 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 A 182 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 A 182 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 A 182 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 A 182 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 A 182 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 A 182 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 A 182 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 A 182 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 A 182 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 A 182 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 A 182 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP THR SEQRES 1 B 190 GLY ASP THR ARG PRO ARG PHE LEU TRP GLN PRO LYS ARG SEQRES 2 B 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE SEQRES 3 B 190 LEU ASP ARG TYR PHE TYR ASN GLN GLU GLU SER VAL ARG SEQRES 4 B 190 PHE ASP SER ASP VAL GLY GLU PHE ARG ALA VAL THR GLU SEQRES 5 B 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 B 190 ASP ILE LEU GLU GLN ALA ARG ALA ALA VAL ASP THR TYR SEQRES 7 B 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 B 190 GLN ARG ARG VAL GLN PRO LYS VAL THR VAL TYR PRO SER SEQRES 9 B 190 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 B 190 SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 B 190 TRP PHE LEU ASN GLY GLN GLU GLU LYS ALA GLY MET VAL SEQRES 12 B 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 B 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 B 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 B 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 C 182 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 C 182 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 C 182 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 C 182 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 C 182 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 C 182 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 C 182 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 C 182 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 C 182 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 C 182 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 C 182 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 C 182 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 C 182 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 C 182 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP THR SEQRES 1 D 190 GLY ASP THR ARG PRO ARG PHE LEU TRP GLN PRO LYS ARG SEQRES 2 D 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE SEQRES 3 D 190 LEU ASP ARG TYR PHE TYR ASN GLN GLU GLU SER VAL ARG SEQRES 4 D 190 PHE ASP SER ASP VAL GLY GLU PHE ARG ALA VAL THR GLU SEQRES 5 D 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 D 190 ASP ILE LEU GLU GLN ALA ARG ALA ALA VAL ASP THR TYR SEQRES 7 D 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 D 190 GLN ARG ARG VAL GLN PRO LYS VAL THR VAL TYR PRO SER SEQRES 9 D 190 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 D 190 SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 D 190 TRP PHE LEU ASN GLY GLN GLU GLU LYS ALA GLY MET VAL SEQRES 12 D 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 D 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 D 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 D 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 E 15 ARG VAL LEU GLY LEU VAL LEU LEU ARG GLY GLU ASN LEU SEQRES 2 E 15 VAL SER SEQRES 1 F 15 ARG VAL LEU GLY LEU VAL LEU LEU ARG GLY GLU ASN LEU SEQRES 2 F 15 VAL SER HET NAG A 201 28 HET NAG C 201 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 7 NAG 2(C8 H15 N O6) FORMUL 9 HOH *(H2 O) HELIX 1 AA1 GLU A 47 PHE A 51 1 5 HELIX 2 AA2 ALA A 56 SER A 77 1 22 HELIX 3 AA3 THR B 51 LEU B 53 5 3 HELIX 4 AA4 GLY B 54 TRP B 61 1 8 HELIX 5 AA5 GLN B 64 ALA B 73 1 10 HELIX 6 AA6 ALA B 73 TYR B 78 1 6 HELIX 7 AA7 TYR B 78 GLU B 87 1 10 HELIX 8 AA8 GLU C 47 ALA C 52 1 6 HELIX 9 AA9 ALA C 56 SER C 77 1 22 HELIX 10 AB1 THR D 51 ARG D 55 5 5 HELIX 11 AB2 PRO D 56 TRP D 61 1 6 HELIX 12 AB3 GLN D 64 ALA D 73 1 10 HELIX 13 AB4 TYR D 78 GLU D 87 1 10 HELIX 14 AB5 SER D 88 THR D 90 5 3 SHEET 1 AA1 8 GLU A 40 TRP A 43 0 SHEET 2 AA1 8 ASP A 29 ASP A 35 -1 N ASP A 35 O GLU A 40 SHEET 3 AA1 8 SER A 19 PHE A 26 -1 N PHE A 24 O ILE A 31 SHEET 4 AA1 8 HIS A 5 ASN A 15 -1 N ILE A 8 O ASP A 25 SHEET 5 AA1 8 PHE B 7 PHE B 18 -1 O ARG B 13 N GLN A 9 SHEET 6 AA1 8 ARG B 23 TYR B 32 -1 O ARG B 29 N LYS B 12 SHEET 7 AA1 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 AA1 8 PHE B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AA2 2 ALA A 52 SER A 53 0 SHEET 2 AA2 2 LEU E 303 GLY E 304 1 O LEU E 303 N SER A 53 SHEET 1 AA3 4 GLU A 88 THR A 93 0 SHEET 2 AA3 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA3 4 PHE A 145 PHE A 153 -1 O LEU A 151 N LEU A 105 SHEET 4 AA3 4 SER A 133 GLU A 134 -1 N SER A 133 O TYR A 150 SHEET 1 AA4 4 GLU A 88 THR A 93 0 SHEET 2 AA4 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA4 4 PHE A 145 PHE A 153 -1 O LEU A 151 N LEU A 105 SHEET 4 AA4 4 LEU A 138 PRO A 139 -1 N LEU A 138 O ARG A 146 SHEET 1 AA5 4 LYS A 126 PRO A 127 0 SHEET 2 AA5 4 ASN A 118 ARG A 123 -1 N ARG A 123 O LYS A 126 SHEET 3 AA5 4 VAL A 160 GLU A 166 -1 O ARG A 164 N THR A 120 SHEET 4 AA5 4 LEU A 174 GLU A 179 -1 O LEU A 174 N VAL A 165 SHEET 1 AA6 4 LYS B 98 PRO B 103 0 SHEET 2 AA6 4 ASN B 113 PHE B 122 -1 O VAL B 116 N TYR B 102 SHEET 3 AA6 4 PHE B 155 THR B 163 -1 O THR B 163 N ASN B 113 SHEET 4 AA6 4 MET B 142 SER B 144 -1 N VAL B 143 O MET B 160 SHEET 1 AA7 4 LYS B 98 PRO B 103 0 SHEET 2 AA7 4 ASN B 113 PHE B 122 -1 O VAL B 116 N TYR B 102 SHEET 3 AA7 4 PHE B 155 THR B 163 -1 O THR B 163 N ASN B 113 SHEET 4 AA7 4 ILE B 148 GLN B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 AA8 4 GLN B 136 GLU B 138 0 SHEET 2 AA8 4 GLU B 128 LEU B 133 -1 N LEU B 133 O GLN B 136 SHEET 3 AA8 4 VAL B 170 GLU B 176 -1 O THR B 172 N PHE B 132 SHEET 4 AA8 4 LEU B 184 ARG B 189 -1 O LEU B 184 N VAL B 175 SHEET 1 AA9 8 GLU C 40 TRP C 43 0 SHEET 2 AA9 8 ASP C 29 ASP C 35 -1 N HIS C 33 O VAL C 42 SHEET 3 AA9 8 SER C 19 PHE C 26 -1 N PHE C 26 O ASP C 29 SHEET 4 AA9 8 HIS C 5 ASN C 15 -1 N ILE C 8 O ASP C 25 SHEET 5 AA9 8 PHE D 7 PHE D 18 -1 O TRP D 9 N TYR C 13 SHEET 6 AA9 8 ARG D 23 TYR D 32 -1 O ARG D 29 N LYS D 12 SHEET 7 AA9 8 GLU D 35 ASP D 41 -1 O SER D 37 N TYR D 30 SHEET 8 AA9 8 PHE D 47 ALA D 49 -1 O ARG D 48 N ARG D 39 SHEET 1 AB1 4 GLU C 88 THR C 93 0 SHEET 2 AB1 4 ASN C 103 ASP C 110 -1 O ILE C 106 N LEU C 92 SHEET 3 AB1 4 PHE C 145 PHE C 153 -1 O HIS C 149 N CYS C 107 SHEET 4 AB1 4 SER C 133 GLU C 134 -1 N SER C 133 O TYR C 150 SHEET 1 AB2 4 GLU C 88 THR C 93 0 SHEET 2 AB2 4 ASN C 103 ASP C 110 -1 O ILE C 106 N LEU C 92 SHEET 3 AB2 4 PHE C 145 PHE C 153 -1 O HIS C 149 N CYS C 107 SHEET 4 AB2 4 LEU C 138 PRO C 139 -1 N LEU C 138 O ARG C 146 SHEET 1 AB3 4 LYS C 126 PRO C 127 0 SHEET 2 AB3 4 ASN C 118 ARG C 123 -1 N ARG C 123 O LYS C 126 SHEET 3 AB3 4 TYR C 161 GLU C 166 -1 O ARG C 164 N THR C 120 SHEET 4 AB3 4 LEU C 174 TRP C 178 -1 O LEU C 174 N VAL C 165 SHEET 1 AB4 4 LYS D 98 PRO D 103 0 SHEET 2 AB4 4 ASN D 113 PHE D 122 -1 O SER D 118 N THR D 100 SHEET 3 AB4 4 PHE D 155 THR D 163 -1 O LEU D 161 N LEU D 115 SHEET 4 AB4 4 MET D 142 SER D 144 -1 N VAL D 143 O MET D 160 SHEET 1 AB5 4 LYS D 98 PRO D 103 0 SHEET 2 AB5 4 ASN D 113 PHE D 122 -1 O SER D 118 N THR D 100 SHEET 3 AB5 4 PHE D 155 THR D 163 -1 O LEU D 161 N LEU D 115 SHEET 4 AB5 4 ILE D 148 GLN D 149 -1 N ILE D 148 O GLN D 156 SHEET 1 AB6 4 GLN D 136 GLU D 138 0 SHEET 2 AB6 4 GLU D 128 LEU D 133 -1 N TRP D 131 O GLU D 138 SHEET 3 AB6 4 VAL D 170 GLU D 176 -1 O GLN D 174 N ARG D 130 SHEET 4 AB6 4 LEU D 184 ARG D 189 -1 O LEU D 184 N VAL D 175 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.03 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.04 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.02 SSBOND 4 CYS C 107 CYS C 163 1555 1555 2.04 SSBOND 5 CYS D 15 CYS D 79 1555 1555 2.06 SSBOND 6 CYS D 117 CYS D 173 1555 1555 2.03 LINK ND2 ASN A 118 C1 NAG A 201 1555 1555 1.44 LINK ND2 ASN C 118 C1 NAG C 201 1555 1555 1.46 CISPEP 1 ASN A 15 PRO A 16 0 8.12 CISPEP 2 THR A 113 PRO A 114 0 3.75 CISPEP 3 TYR B 123 PRO B 124 0 -2.51 CISPEP 4 ASN C 15 PRO C 16 0 4.44 CISPEP 5 THR C 113 PRO C 114 0 -2.30 CISPEP 6 TYR D 123 PRO D 124 0 0.81 CRYST1 95.080 95.080 294.200 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010517 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010517 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003399 0.00000